These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

906 related items for PubMed ID: 18955671

  • 21. Letter by De Ferrari and Verrier regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    De Ferrari GM, Verrier RL.
    Circulation; 2009 Jul 21; 120(3):e20; author reply e22. PubMed ID: 19620521
    [No Abstract] [Full Text] [Related]

  • 22. Evidence regarding clinical use of microvolt T-wave alternans.
    Hohnloser SH, Ikeda T, Cohen RJ.
    Heart Rhythm; 2009 Mar 21; 6(3 Suppl):S36-44. PubMed ID: 19168396
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Microvolt QRS Alternans Without Microvolt T-Wave Alternans in Human Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias.
    Suszko A, Nayyar S, Labos C, Nanthakumar K, Pinter A, Crystal E, Chauhan VS.
    J Am Heart Assoc; 2020 Sep 21; 9(17):e016461. PubMed ID: 32806990
    [Abstract] [Full Text] [Related]

  • 26. T wave alternans for ventricular arrhythmia risk stratification.
    Sturdivant JL, Gold MR.
    Minerva Cardioangiol; 2003 Feb 21; 51(1):15-9. PubMed ID: 12652256
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].
    Daniłowicz-Szymanowicz L, Szwoch M, Raczak J, Raczak G.
    Pol Merkur Lekarski; 2012 Oct 21; 33(196):193-7. PubMed ID: 23272605
    [Abstract] [Full Text] [Related]

  • 29. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.
    Chauhan VS, Selvaraj RJ.
    Curr Opin Cardiol; 2007 Jan 21; 22(1):25-32. PubMed ID: 17143041
    [Abstract] [Full Text] [Related]

  • 30. T wave alternans for ventricular arrhythmia risk stratification.
    Gold MR, Spencer W.
    Curr Opin Cardiol; 2003 Jan 21; 18(1):1-5. PubMed ID: 12496495
    [Abstract] [Full Text] [Related]

  • 31. Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases.
    Benítez Ramos DB, Cabrera Ortega M, Castro Hevia J, Dorantes Sánchez M, Alemán Fernández AA, Castañeda Chirino O, Cruz Cardentey M, Martínez López F, Falcón Rodríguez R.
    Pediatr Cardiol; 2017 Dec 21; 38(8):1663-1671. PubMed ID: 28871362
    [Abstract] [Full Text] [Related]

  • 32. Average T-wave alternans activity in ambulatory ECG records predicts sudden cardiac death in patients with chronic heart failure.
    Monasterio V, Laguna P, Cygankiewicz I, Vázquez R, Bayés-Genís A, de Luna AB, Martínez JP.
    Heart Rhythm; 2012 Mar 21; 9(3):383-9. PubMed ID: 22024149
    [Abstract] [Full Text] [Related]

  • 33. T-wave alternans: marker, mechanism, and methodology for predicting sudden cardiac death.
    Pham Q, Quan KJ, Rosenbaum DS.
    J Electrocardiol; 2003 Mar 21; 36 Suppl():75-81. PubMed ID: 14716596
    [Abstract] [Full Text] [Related]

  • 34. Letter by Madias regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    Madias JE.
    Circulation; 2009 Jul 21; 120(3):e21; author reply e22. PubMed ID: 19620522
    [No Abstract] [Full Text] [Related]

  • 35. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Fishbein DP, Hellkamp AS, Mark DB, Walsh MN, Poole JE, Anderson J, Johnson G, Lee KL, Bardy GH, SCD-HeFT Investigators.
    J Am Coll Cardiol; 2014 Jun 17; 63(23):2560-2568. PubMed ID: 24727258
    [Abstract] [Full Text] [Related]

  • 36. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?
    Armoundas AA, Hohnloser SH, Ikeda T, Cohen RJ.
    Nat Clin Pract Cardiovasc Med; 2005 Oct 17; 2(10):522-8. PubMed ID: 16186850
    [Abstract] [Full Text] [Related]

  • 37. Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study.
    Shizuta S, Ando K, Nobuyoshi M, Ikeda T, Yoshino H, Hiramatsu S, Kazatani Y, Yamashiro K, Okajima K, Kajiya T, Kobayashi Y, Kato T, Fujii S, Mitsudo K, Inoue K, Ito H, Haruna Y, Doi T, Nishio Y, Ozasa N, Nishiyama K, Kita T, Morimoto T, Kimura T, PREVENT-SCD Investigators.
    Clin Res Cardiol; 2012 Feb 17; 101(2):89-99. PubMed ID: 21960418
    [Abstract] [Full Text] [Related]

  • 38. Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description.
    Cheng A, Dalal D, Butcher B, Norgard S, Zhang Y, Dickfeld T, Eldadah ZA, Ellenbogen KA, Guallar E, Tomaselli GF.
    J Am Heart Assoc; 2013 Feb 22; 2(1):e000083. PubMed ID: 23525420
    [Abstract] [Full Text] [Related]

  • 39. Microvolt T-wave alternans in short QT syndrome.
    Maury P, Extramiana F, Giustetto C, Cardin C, Rollin A, Duparc A, Mondoly P, Denjoy I, Delay M, Messali A, Leenhardt A, Marangoni D.
    Pacing Clin Electrophysiol; 2012 Dec 22; 35(12):1413-9. PubMed ID: 22897428
    [Abstract] [Full Text] [Related]

  • 40. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
    Klingenheben T, Credner S, Li YG, Bender B, Hohnloser SH.
    Z Kardiol; 2000 Dec 22; 89 Suppl 3():57-61. PubMed ID: 10810786
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.